United States

Ion Beam Applications SA (IBAB.BR)

IBAB.BR on Brussels Stock Exchange

23 Jan 2017
Change (% chg)

€-0.34 (-0.84%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low


Chart for IBAB.BR


Ion Beam Applications SA (IBA) is a Belgium-based company that develops and markets technologies, pharmaceutical products and tailored solutions for the healthcare sector, with emphasis on cancer diagnosis and therapy. IBA is also active in the sterilization and ionization field. The Company operates through two business... (more)


Beta: 0.89
Market Cap(Mil.): €1,206.05
Shares Outstanding(Mil.): 29.76
Dividend: 1.01
Yield (%): 2.50


  IBAB.BR Industry Sector
P/E (TTM): 21.33 59.99 30.38
EPS (TTM): 1.90 -- --
ROI: 33.38 7.20 14.86
ROE: 42.73 10.77 16.28

IBA lowers operating margin guidance on weak dosimetry markets

BRUSSELS, Nov 16 Belgium's IBA, which makes proton therapy machines to treat cancer, slightly cut its margin expectations on Wednesday, due to weakness in its business measuring out doses of radiation.

Nov 16 2016

BRIEF-IBA Q3 YTD revenue up 19.3 pct at 225.3 mln euros

* Says Q3 2016 year to date group revenues of 225.3 million euros ($242.2 million), up 19.3 pct year-on-year

Nov 16 2016

BRIEF-Ion Beam Applications announces first IBA proton therapy center in Russia

* Announces delivery and installation of cyclone 230 for a new proton therapy center in Dimitrovgrad

Oct 19 2016

BRIEF-IBA signs contract to install Proteus One compact proton therapy center in Abu Dhabi

* Signs contract to install Proteus One compact proton therapy center in Abu Dhabi, UAE Source text for Eikon: Further company coverage: (Gdynia Newsroom)

Sep 27 2016

BRIEF-IBA signs contract with Medstar for the purchase of a proton therapy system

* Announced on Sunday that it signed a contract with Medstar (Shanghai) Leasing Co., Ltd, a subsidiary of Concord Medical Services Holdings Limited, for the purchase, installation and maintenance of a proton therapy system

Sep 26 2016

BRIEF-Ion Beam Applications H1 net profit down at 8.3 million euros

* H1 revenue 145.1 million euros versus 121.0 million euros ($136.39 million) year ago

Aug 25 2016

BRIEF-IBA invests 2 million US dollars in HIL Applied Medical Ltd.

* IBA invests in HIL Applied Medical Ltd. to develop laser-based proton therapy system

Aug 23 2016

Earnings vs. Estimates